Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 3/20 | 0.64 |
| ▸ | RAMP3 | O60896 | 6/20 | 0.62 |
| ▸ | CALCR | P30988 | 6/20 | 0.62 |
| ▸ | TFPI | P10646 | 4/20 | 0.62 |
| ▸ | NPY2R | P49146 | 7/20 | 0.61 |
| ▸ | NPY4R | P50391 | 7/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.61 |
| ▸ | NPY1R | P25929 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29614957 | 0.96 | TFPI (0.63) | CXCR4RAMP3CALCRTFPINPY2R | |
| SCHEMBL30364495 | 0.93 | TFPI (0.68) | CXCR4RAMP3CALCRTFPINPY2R | |
| SCHEMBL31418387 | 0.88 | TFPI (0.63) | CXCR4RAMP3CALCRTFPINPY2R | |
| SCHEMBL29615082 | 0.84 | CALCR (0.61) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30300729 | 0.83 | REN (0.63) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL30432005 | 0.83 | CALCR (0.62) | CALCRTFPINPY2RNPY4RNPY5R | |
| Melectin SCHEMBL30448502 | 0.83 | REN (0.62) | TFPI | |
| SCHEMBL8973220 | 0.82 | CALCR (0.57) | CXCR4CALCRTFPINPY2RNPY4R | |
| SCHEMBL30679464 | 0.82 | CALCR (0.63) | CXCR4CALCR | |
| SCHEMBL30497011 | 0.82 | OPRD1 (0.67) | CALCRTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059926-A | Heterocyclic degradation determinants for target protein degradation | C4医药公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-121910847-A | Use of caerin 1.1.1/1.9 and polymyxin B composition in preparation of anti-Acinetobacter baumannii medicine | 中奥生物医药技术(广东)有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-121910847-A | Use of caerin 1.1.1/1.9 and polymyxin B composition in preparation of anti-Acinetobacter baumannii medicine | 中奥生物医药技术(广东)有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-121796558-A | Caerin 1.1.1/1.9 application in preparing antiviral drug | 中奥生物医药技术(广东)有限公司 | 2026-04-07 | — | — | CN | disclosed |
| CN-121796558-A | Caerin 1.1.1/1.9 application in preparing antiviral drug | 中奥生物医药技术(广东)有限公司 | 2026-04-07 | — | — | CN | disclosed |
| CN-118812656-B | Iodine-131 marked small molecular polypeptide TCMP-Y1 and preparation method and application thereof | 广州港湾医疗器械有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-118812656-A | Iodine-131 marked small molecular polypeptide TCMP-Y1 and preparation method and application thereof | 广州港湾医疗器械有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-118440096-A | Degradation stator and degradation determinant for N/O-ligation of protein degradation | C4医药公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117866069-B | Iodine-131 marked small molecule polypeptide TFMP-Y4 and preparation method and application thereof | 广州港湾医疗器械有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-117866069-B | Iodine-131 marked small molecule polypeptide TFMP-Y4 and preparation method and application thereof | 广州港湾医疗器械有限公司 | 2024-07-19 | — | — | CN | disclosed |
| CN-117982626-A | Application of F1/F3 polypeptide in preparation of medicines for inducing tumor cell apoptosis | 中奥生物医药技术(广东)有限公司 | 2024-05-07 | — | — | CN | disclosed |